Glioblastoma Multiforme News and Research

RSS
Glioblastoma Multiforme is a fast-growing type of central nervous system tumor that forms from glial (supportive) tissue of the brain and spinal cord and has cells that look very different from normal cells. Glioblastoma multiforme usually occurs in adults and affects the brain more often than the spinal cord. Also called GBM, glioblastoma, and grade IV astrocytoma.
CWRU investigator receives $2.82 million NIH grant to make stealth bombs for brain cancer treatment

CWRU investigator receives $2.82 million NIH grant to make stealth bombs for brain cancer treatment

FDA approves expanded indication for Optune device for brain cancer patients

FDA approves expanded indication for Optune device for brain cancer patients

Scientists map EGFRvIII mutant that causes brain cancer

Scientists map EGFRvIII mutant that causes brain cancer

Innovative way may stop spread of glioblastoma multiforme

Innovative way may stop spread of glioblastoma multiforme

DelMar presents updated VAL-083 Phase I/II trial data at GBM2015 meeting

DelMar presents updated VAL-083 Phase I/II trial data at GBM2015 meeting

Northwestern University receives $11.7 million NCI grant to use nanotechnology for cancer treatments

Northwestern University receives $11.7 million NCI grant to use nanotechnology for cancer treatments

NW Bio's DCVax-L Phase III trial ongoing for treatment of patients with newly diagnosed GBM

NW Bio's DCVax-L Phase III trial ongoing for treatment of patients with newly diagnosed GBM

DelMar closes on $2.6 million registered direct placement

DelMar closes on $2.6 million registered direct placement

Complete removal of visible tumor improves outcomes in children with high-grade glioma

Complete removal of visible tumor improves outcomes in children with high-grade glioma

DelMar obtains additional funding to support ongoing research project with lead product candidate VAL-083

DelMar obtains additional funding to support ongoing research project with lead product candidate VAL-083

AbbVie's venetoclax Phase 2 trial meets primary endpoint in patients with relapsed/refractory CLL with 17P deletion

AbbVie's venetoclax Phase 2 trial meets primary endpoint in patients with relapsed/refractory CLL with 17P deletion

Ludwig, CRI launch clinical trials to evaluate immunotherapies for treatment of GBM and solid tumors

Ludwig, CRI launch clinical trials to evaluate immunotherapies for treatment of GBM and solid tumors

Global GBM therapeutics market to expand at CAGR of 10.9% to $623 million by 2020

Global GBM therapeutics market to expand at CAGR of 10.9% to $623 million by 2020

Scientists and clinicians from across the UK come together to address treatment of brain tumors

Scientists and clinicians from across the UK come together to address treatment of brain tumors

NW Bio releases promising new data on DCVax-Direct Phase I trial for inoperable solid tumors

NW Bio releases promising new data on DCVax-Direct Phase I trial for inoperable solid tumors

Small Business Administration presents prestigious Tibbetts Award to Bexion Pharmaceuticals

Small Business Administration presents prestigious Tibbetts Award to Bexion Pharmaceuticals

Abbvie presents venetoclax Phase 1 results in patients with multiple myeloma at ASCO 2015

Abbvie presents venetoclax Phase 1 results in patients with multiple myeloma at ASCO 2015

Additional preclinical data on DelMar’s VAL-083 to treat temozolomide-resistant GBM presented at AACR

Additional preclinical data on DelMar’s VAL-083 to treat temozolomide-resistant GBM presented at AACR

Experimental cancer drug shows promise against incurable paediatric brain cancer

Experimental cancer drug shows promise against incurable paediatric brain cancer

DelMar to present new data on development of VAL-083 at 2015 ASCO Annual Meeting

DelMar to present new data on development of VAL-083 at 2015 ASCO Annual Meeting